Zhu G, Xiong J, Li X, He Z, Zhong S, Chen J
Light Sci Appl. 2024; 13(1):258.
PMID: 39300070
PMC: 11413014.
DOI: 10.1038/s41377-024-01617-9.
Zhang Z, You Y, Ge M, Lin H, Shi J
J Nanobiotechnology. 2023; 21(1):319.
PMID: 37674191
PMC: 10483742.
DOI: 10.1186/s12951-023-02084-x.
Baghban H, Hasanzadeh M, Liu Y, Seidi F
Biosensors (Basel). 2022; 12(10).
PMID: 36291047
PMC: 9599316.
DOI: 10.3390/bios12100911.
Madiha S, Batool Z, Tabassum S, Liaquat L, Sadir S, Shahzad S
PLoS One. 2021; 16(11):e0258928.
PMID: 34767546
PMC: 8589152.
DOI: 10.1371/journal.pone.0258928.
Masato A, Sandre M, Antonini A, Bubacco L
Curr Neuropharmacol. 2021; 19(10):1618-1639.
PMID: 33535956
PMC: 8977628.
DOI: 10.2174/1570159X19666210203162617.
Neuroprotective and Neurorestorative Effects of Extract in the MPTP/MPP-Induced Mouse and Cellular Models of Parkinson's Disease.
Noonong K, Sobhon P, Sroyraya M, Chaithirayanon K
Front Neurosci. 2021; 14:575459.
PMID: 33408606
PMC: 7779621.
DOI: 10.3389/fnins.2020.575459.
Hepcidin Decreases Rotenone-Induced α-Synuclein Accumulation Autophagy in SH-SY5Y Cells.
Li M, Hu J, Yuan X, Shen L, Zhu L, Luo Q
Front Mol Neurosci. 2020; 13:560891.
PMID: 33177988
PMC: 7596286.
DOI: 10.3389/fnmol.2020.560891.
Absence of a synergic nigral proapoptotic effect triggered by REM sleep deprivation in the rotenone model of Parkinson´s disease.
Kmita L, Ilkiw J, Rodrigues L, Targa A, Noseda A, Dos-Santos P
Sleep Sci. 2020; 12(3):196-202.
PMID: 31890096
PMC: 6932851.
DOI: 10.5935/1984-0063.20190078.
Impaired dopamine metabolism in Parkinson's disease pathogenesis.
Masato A, Plotegher N, Boassa D, Bubacco L
Mol Neurodegener. 2019; 14(1):35.
PMID: 31488222
PMC: 6728988.
DOI: 10.1186/s13024-019-0332-6.
GRK5 - A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders.
Hendrickx J, van Gastel J, Leysen H, Santos-Otte P, Premont R, Martin B
Front Pharmacol. 2019; 9:1484.
PMID: 30618771
PMC: 6304357.
DOI: 10.3389/fphar.2018.01484.
Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice.
Wang R, Zhao X, Xu J, Wen Y, Li A, Lu M
Cell Death Dis. 2018; 9(3):352.
PMID: 29500411
PMC: 5834463.
DOI: 10.1038/s41419-018-0381-8.
The Role of Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in Neuropathology and Neurodegeneration.
Chen C, Joshi A, Mochly-Rosen D
Acta Neurol Taiwan. 2017; 25(4):111-123.
PMID: 28382610
PMC: 10618051.
Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
Dutta D, Ali N, Banerjee E, Singh R, Naskar A, Paidi R
Mol Neurobiol. 2017; 55(1):804-821.
PMID: 28062948
DOI: 10.1007/s12035-016-0328-y.
Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.
Cheon S, Jang I, Lee M, Kim D, Jeon H, Cha D
Pharm Biol. 2016; 55(1):481-486.
PMID: 27937005
PMC: 5490792.
DOI: 10.1080/13880209.2016.1251468.
MPP-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.
Cunha M, Pazini F, Lieberknecht V, Budni J, Oliveira A, Rosa J
Mol Neurobiol. 2016; 54(8):6356-6377.
PMID: 27722926
DOI: 10.1007/s12035-016-0147-1.
Protective Mechanisms of Flavonoids in Parkinson's Disease.
Magalingam K, Radhakrishnan A, Haleagrahara N
Oxid Med Cell Longev. 2015; 2015:314560.
PMID: 26576219
PMC: 4630416.
DOI: 10.1155/2015/314560.
Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons.
Branch S, Sharma R, Beckstead M
J Neurosci. 2014; 34(28):9310-8.
PMID: 25009264
PMC: 4087208.
DOI: 10.1523/JNEUROSCI.4228-13.2014.
Role of aldehyde dehydrogenase 2 in 1-methy-4-phenylpyridinium ion-induced aldehyde stress and cytotoxicity in PC12 cells.
Chen A, Zhang P, Yin W, Wang L, Zou W, Tang X
Neurochem Res. 2014; 39(9):1767-75.
PMID: 25005621
DOI: 10.1007/s11064-014-1376-1.
Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing.
Saha K, Sambo D, Richardson B, Lin L, Butler B, Villarroel L
J Biol Chem. 2014; 289(32):22246-57.
PMID: 24962577
PMC: 4139236.
DOI: 10.1074/jbc.M114.563056.
Identification of licopyranocoumarin and glycyrurol from herbal medicines as neuroprotective compounds for Parkinson's disease.
Fujimaki T, Saiki S, Tashiro E, Yamada D, Kitagawa M, Hattori N
PLoS One. 2014; 9(6):e100395.
PMID: 24960051
PMC: 4069009.
DOI: 10.1371/journal.pone.0100395.